An Lu

1.1k total citations
20 papers, 949 citations indexed

About

An Lu is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, An Lu has authored 20 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 13 papers in Immunology and 3 papers in Biomedical Engineering. Recurrent topics in An Lu's work include CAR-T cell therapy research (16 papers), Immunotherapy and Immune Responses (10 papers) and Immune Cell Function and Interaction (6 papers). An Lu is often cited by papers focused on CAR-T cell therapy research (16 papers), Immunotherapy and Immune Responses (10 papers) and Immune Cell Function and Interaction (6 papers). An Lu collaborates with scholars based in United States, Netherlands and China. An Lu's co-authors include Aaron E. Foster, Cliona M. Rooney, Malcolm K. Brenner, Adham S. Bear, John Craddock, Martin Pulé, Mariam Khalil, Catherine M. Bollard, Helen E. Heslop and Gianpietro Dotti and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Controlled Release.

In The Last Decade

An Lu

20 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
An Lu United States 10 838 400 323 298 270 20 949
ChingLam W. Wong United States 7 944 1.1× 381 1.0× 312 1.0× 323 1.1× 359 1.3× 8 1.0k
Lynsey M. Whilding United Kingdom 16 913 1.1× 571 1.4× 312 1.0× 236 0.8× 295 1.1× 21 1.2k
Reona Sakemura United States 13 717 0.9× 261 0.7× 261 0.8× 227 0.8× 249 0.9× 54 879
Qiangzhong Ma United States 14 884 1.1× 503 1.3× 257 0.8× 274 0.9× 261 1.0× 18 1.1k
Elizabeth L. Siegler United States 14 910 1.1× 398 1.0× 444 1.4× 198 0.7× 346 1.3× 37 1.2k
Virna Marin Italy 14 948 1.1× 534 1.3× 217 0.7× 374 1.3× 338 1.3× 26 1.1k
Claudia Heuser Germany 16 843 1.0× 520 1.3× 261 0.8× 209 0.7× 220 0.8× 19 994
Simon Thomas United Kingdom 10 677 0.8× 201 0.5× 266 0.8× 215 0.7× 279 1.0× 28 773
Connie P.M. Duong United States 15 1.1k 1.3× 683 1.7× 259 0.8× 313 1.1× 379 1.4× 24 1.4k

Countries citing papers authored by An Lu

Since Specialization
Citations

This map shows the geographic impact of An Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An Lu more than expected).

Fields of papers citing papers by An Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by An Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An Lu. The network helps show where An Lu may publish in the future.

Co-authorship network of co-authors of An Lu

This figure shows the co-authorship network connecting the top 25 collaborators of An Lu. A scholar is included among the top collaborators of An Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An Lu. An Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Weiran, Xue Zhang, Rui Li, et al.. (2024). Lipid core-shell nanoparticles co-deliver FOLFOX regimen and siPD-L1 for synergistic targeted cancer treatment. Journal of Controlled Release. 368. 52–65. 13 indexed citations
2.
Lu, An, et al.. (2023). Therapeutic Effect of Polaprezinc on Reflux Esophagitis in the Rat Model. Digestive Diseases and Sciences. 68(8). 3283–3292. 3 indexed citations
3.
Collinson-Pautz, Matthew R., Wei-Chun Chang, An Lu, et al.. (2019). Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies. Leukemia. 33(9). 2195–2207. 64 indexed citations
4.
Collinson-Pautz, Matthew R., Éva Morschl, An Lu, et al.. (2018). Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal Switches. Molecular Therapy — Oncolytics. 12. 124–137. 69 indexed citations
5.
6.
Foster, Aaron E., Aruna Mahendravada, Nicholas Shinners, et al.. (2017). Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40. Molecular Therapy. 25(9). 2176–2188. 93 indexed citations
7.
Foster, Aaron E., MyLinh Duong, An Lu, et al.. (2016). Inducible MyD88/CD40 (iMC) Costimulation Provides Ligand-Dependent Tumor Eradication By CD123-Specific Chimeric Antigen Receptor T Cells. Blood. 128(22). 4551–4551. 2 indexed citations
8.
Foster, Aaron E., Peter S. Chang, Pei‐Yi Lin, et al.. (2016). Efficacy and safety of Her2-targeted chimeric antigen receptor (CAR) T cells using MyD88/CD40 costimulation and iCaspase-9 suicide switch.. Journal of Clinical Oncology. 34(15_suppl). 3050–3050. 1 indexed citations
9.
Foster, Aaron E., Tania Véliz Rodríguez, David Torres, et al.. (2016). 746. Go-TCR: Inducible MyD88/CD40 (iMC) Enhances Proliferation and Survival of Tumor-Specific TCR-Modified T Cells, Increasing Anti-Tumor Efficacy. Molecular Therapy. 24. S294–S295. 1 indexed citations
10.
Pentcheva‐Hoang, Tsvetelina, David Torres, Tania Véliz Rodríguez, et al.. (2016). Inducible MyD88/CD40 (iMC) Enhances Proliferation and Survival of Tumor-Specific TCR-Modified T Cells and Improves Anti-Tumor Efficacy in Myeloma. Blood. 128(22). 4550–4550. 2 indexed citations
11.
Foster, Aaron E., Peter S. Chang, Pei‐Yi Lin, et al.. (2015). MyD88/CD40-based costimulation to enhance survival and proliferation of chimeric antigen receptor (CAR)-modified T cells.. Journal of Clinical Oncology. 33(15_suppl). 3064–3064. 2 indexed citations
12.
Foster, Aaron E., Aruna Mahendravada, Nicholas Shinners, et al.. (2015). Inducible MyD88/CD40 Allows Rimiducid-Dependent Activation to Control Proliferation and Survival of Chimeric Antigen Receptor-Modified T Cells. Blood. 126(23). 4295–4295. 2 indexed citations
13.
Foster, Aaron E., An Lu, Annemarie Moseley, et al.. (2015). Inducible MyD88/CD40 Enhances Proliferation and Survival of PRAME-Specific TCR-Engineered T Cells and Increases Anti-Tumor Effects in Myeloma. Blood. 126(23). 1886–1886. 1 indexed citations
14.
Craddock, John, An Lu, Adham S. Bear, et al.. (2010). Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b. Journal of Immunotherapy. 33(8). 780–788. 427 indexed citations
15.
Cruz, Carolina Colli, Ann M. Leen, Stephanie Ku, et al.. (2010). Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma. Leukemia & lymphoma. 51(5). 870–880. 33 indexed citations
16.
Kaka, Anjum S., Donald R. Shaffer, Ann M. Leen, et al.. (2009). Genetic Modification of T Cells With IL-21 Enhances Antigen Presentation and Generation of Central Memory Tumor-specific Cytotoxic T-lymphocytes. Journal of Immunotherapy. 32(7). 726–736. 21 indexed citations
17.
Foster, Aaron E., Fatma Visal Okur, Ettore Biagi, et al.. (2009). Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression. Molecular Cancer. 8(1). 106–106. 4 indexed citations
18.
Foster, Aaron E., Gianpietro Dotti, An Lu, et al.. (2008). Antitumor Activity of EBV-specific T Lymphocytes Transduced With a Dominant Negative TGF-β Receptor. Journal of Immunotherapy. 31(5). 500–505. 175 indexed citations
19.
Foster, Aaron E., Sunkuk Kwon, Ke Shi, et al.. (2008). In vivo fluorescent optical imaging of cytotoxic T lymphocyte migration using IRDye800CW near-infrared dye. Applied Optics. 47(31). 5944–5944. 18 indexed citations
20.
Foster, Aaron E., Ann M. Leen, Timothy Lee, et al.. (2007). Autologous Designer Antigen-presenting Cells by Gene Modification of T Lymphocyte Blasts With IL-7 and IL-12. Journal of Immunotherapy. 30(5). 506–516. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by ChingLam W. Wong Breakdown of academic impact, for papers by Lynsey M. Whilding Breakdown of academic impact, for papers by Reona Sakemura Breakdown of academic impact, for papers by Qiangzhong Ma Breakdown of academic impact, for papers by Elizabeth L. Siegler Breakdown of academic impact, for papers by Virna Marin Breakdown of academic impact, for papers by Claudia Heuser Breakdown of academic impact, for papers by Simon Thomas Breakdown of academic impact, for papers by Connie P.M. Duong
Rankless by CCL
2026